HIVE Blockchain Technologies Ltd. (CVE:HIV – Free Report) – Equities researchers at Roth Capital issued their Q3 2025 earnings per share estimates for shares of HIVE Blockchain Technologies in a research report issued on Wednesday, December 18th. Roth Capital analyst D. Aftahi expects that the company will post earnings per share of ($0.19) for the quarter. Roth Capital currently has a “Strong-Buy” rating on the stock. Roth Capital also issued estimates for HIVE Blockchain Technologies’ Q4 2025 earnings at ($0.11) EPS, FY2025 earnings at ($0.55) EPS, Q1 2026 earnings at ($0.09) EPS, Q2 2026 earnings at ($0.03) EPS, Q3 2026 earnings at ($0.03) EPS, Q4 2026 earnings at $0.03 EPS, FY2026 earnings at ($0.11) EPS, FY2027 earnings at $0.13 EPS and FY2028 earnings at ($0.17) EPS.
A number of other research analysts have also issued reports on the stock. Northland Capmk raised shares of HIVE Blockchain Technologies to a “strong-buy” rating in a research note on Thursday, September 19th. Cantor Fitzgerald raised HIVE Blockchain Technologies to a “strong-buy” rating in a report on Tuesday, October 29th.
HIVE Blockchain Technologies Stock Performance
HIVE Blockchain Technologies Ltd. is a services company in the Business Services industry.
See Also
- Five stocks we like better than HIVE Blockchain Technologies
- What is the Nikkei 225 index?
- XPO Stock Gains Momentum as U.S. Trade Outlook Evolves
- Mastering Discipline: Overcoming Emotional Challenges In Trading
- CarMax Gets in Gear: Is Now the Time to Buy?
- Best Aerospace Stocks Investing
- Qubit Combat: 2 Stocks Battle for Quantum Supremacy
Receive News & Ratings for HIVE Blockchain Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HIVE Blockchain Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
